1991
DOI: 10.1007/bf02262726
|View full text |Cite
|
Sign up to set email alerts
|

The APE nebuliser — a new delivery system for the alveolar targeting of particulate technetium 99m diethylene triamine penta-acetic acid

Abstract: We report the validation of a new delivery system--aerosol production equipment (known by the acronym APE), which generates a particulate aerosol of technetium 99m diethylene triamine penta-acetic acid (DTPA) with a mass-median aerodynamic diameter of 0.35 microns and a geometric standard deviation of 1.8 Twenty subjects were studied; in group 1 were 12 healthy men with normal spirometry; in group 2 were 8 men with AIDS who had mildly abnormal lung function following an episode of pneumocystis pneumonia-spirom… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
7
0

Year Published

1992
1992
2012
2012

Publication Types

Select...
6
1

Relationship

1
6

Authors

Journals

citations
Cited by 11 publications
(7 citation statements)
references
References 23 publications
0
7
0
Order By: Relevance
“…Generation of submicronic particles with reasonably high output for inhalation has been a task for PE diagnostic use in nuclear and thoracic medicine. This problem was tackled, e.g., by Burch et al (1986) using Technegas [99mTc-labelled carbon particles with sizes < 200 nm dispersed in argon gas (Strong and Agnew, 1989;Isawa et al, 1991)]; and more recently by Miller et al (1991) using another novel aerosol delivery system. Note that for most of the alternatives to Tc99m DTPA aerosols, an increased retention due to slow clearance from the lung will increase the radiation dose to the patient [e.g.…”
Section: Clinical Use Of Spect In Lung and Aerosol Studiesmentioning
confidence: 99%
See 1 more Smart Citation
“…Generation of submicronic particles with reasonably high output for inhalation has been a task for PE diagnostic use in nuclear and thoracic medicine. This problem was tackled, e.g., by Burch et al (1986) using Technegas [99mTc-labelled carbon particles with sizes < 200 nm dispersed in argon gas (Strong and Agnew, 1989;Isawa et al, 1991)]; and more recently by Miller et al (1991) using another novel aerosol delivery system. Note that for most of the alternatives to Tc99m DTPA aerosols, an increased retention due to slow clearance from the lung will increase the radiation dose to the patient [e.g.…”
Section: Clinical Use Of Spect In Lung and Aerosol Studiesmentioning
confidence: 99%
“…Burch et al (1986) used it to compare the transverse lung slices in the same patient after Technegas inhalation and lung perfusion. Similarly Miller et al (1991) utilized SPECT (transverse slices) to confirm the homogeneity of intrapulmonary deposition with minimal trachea! and extrapulmonary (oropharynx and stomach) deposition with their aerosol (mass median aerodynamic diameter, MMAD, 0.35pm, geometric standard deviation, GSD, 1.8) .…”
Section: Applications Of Spect In Aerosol Research Studiesmentioning
confidence: 99%
“…In these systems, minimal initial fluid volumes are required and the whole volume of the generated aerosol will be inhaled without loss of aerosol during expiration. In the ambient dry atmosphere inside the aerosol reservoir, the aerosol droplets will evaporate depending on relative humidity and solute content [8]. Under optimal drying conditions it is possible to generate dry particles [6,8,9].…”
mentioning
confidence: 99%
“…In the ambient dry atmosphere inside the aerosol reservoir, the aerosol droplets will evaporate depending on relative humidity and solute content [8]. Under optimal drying conditions it is possible to generate dry particles [6,8,9]. Depending on choice of the solute concentration and drying conditions, the diameter of the aerosol particles will decrease during evaporation [8], improving penetration in the peripheral airways after inhalation with increased deposition after hygroscopic growth [8,10].…”
mentioning
confidence: 99%
See 1 more Smart Citation